Growth Stocks
114 articlesLook for pieces that explain fee analysis and trading basics, compare adjacent choices and show how nearby terms appears in applications, disclosures, statements or official pages.
Why Dividend Income Could Shape Retirement Portfolios Through 2030
Dividend-paying stocks can provide cash during market declines, but a high yield alone can mislead. For retirees, the balance between income now and dividend growth over time may matter through 2030.
Why Investors Look to Smaller, Fast-Growing Tech Stocks
The investor looks for tech companies with fast revenue growth, rising margins and room to scale. Silicon Motion's recent results show the kind of growth that draws attention, but the approach still carries company-specific and market risks.
Market Cap Sets the Scale for a Stock's Upside
A tenfold gain would take a $2 billion company to $20 billion, but a $1.2 trillion company would need to reach $12 trillion. Market cap helps frame the math, not predict the outcome.
Tech stock valuations push investors to rethink as returns beat the market
Tech ETFs like QQQ and VGT have posted annual returns of 16% to 26% in recent years. But high prices and market uncertainty are making some investors question their tech exposure.
Steris dividend hike puts spotlight on stock price and future gains
Steris raised its dividend to $0.69 per share but the stock closed near its 52-week low. With analysts projecting upside, investors face a choice between income and growth potential
Anthropic IPO tests investor appetite for AI exposure
Anthropic's planned IPO aims for a $2 trillion valuation and could become the largest in history. But with most IPOs lagging after their debut and S&P 500 rules delaying index inclusion, investors face real risks and volatility
South Korea stock market outpaces global rivals in 2026
South Korea's Kospi index has soared nearly 60 percent in 2026, led by Samsung and SK Hynix, while the iShares MSCI South Korea ETF has jumped 88 percent-raising questions about whether this rally can continue and how U.S. investors can participate
Merck faces high-stakes decision on Moderna acquisition
Merck's reliance on Keytruda for nearly half its sales is pushing the company to consider a bold move-acquiring Moderna for $210-$215 per share to secure next-generation cancer vaccine technology
Nvidia faces trillion dollar AI bet as supply strains test growth
Nvidia is sticking to its $4 trillion AI market forecast for 2030 but supply shortages and rising costs are putting pressure on margins and investor confidence
JPMorgan cuts Adobe price target as user growth outpaces revenue
JPMorgan lowered its Adobe price target to 315 dollars despite strong earnings, citing slower revenue growth as the company prioritizes expanding its user base over immediate profits
Nvidia, Alphabet, and American Express Defy Market Doubts With Relentless Growth
Nvidia projects a 70 percent revenue jump next year, Google Cloud sales soar 82 percent, and American Express raises its outlook after double-digit growth-giving investors new reasons to reconsider these blue-chip stocks.
Diversification shields portfolios from sudden market drops
Relying on a handful of high-flying stocks can leave your investments exposed if the market plunges. Learn how a mix of sectors and steady dividend payers can help protect your portfolio from lasting losses
Nasdaq Composite faces volatile path as tech valuations soar
If the Nasdaq Composite repeats its historical 11 percent annual return, the index could triple by 2036-but past periods of stagnation and current tech valuations highlight the risk of sharp reversals
Vertiv stock faces high expectations as analyst sees more upside
Vertiv shares have soared over 1,000 percent in five years but a veteran options strategist argues the AI infrastructure supplier still offers room for gains despite a lofty valuation and mounting volatility risk
Smart Money Backs European AI Lab as Biotech Bets Stumble
Samsung's $3.5 billion investment in French AI startup Mistral signals global demand for AI infrastructure even as biotech stocks like Ionis and Novartis face setbacks after disappointing drug trial results
Retirees Face a Yield or Growth Dilemma in Volatile Markets
Many retirees hesitate to spend their savings, fearing they will outlive their money. Choosing between high-yield income and long-term growth investments can create risks if not balanced with cash reserves and a clear withdrawal plan.
Snowflake turns AI panic into a Wall Street windfall
Snowflake stock soared 17 percent after the company revealed that artificial intelligence is now fueling half its growth, flipping the narrative that AI would destroy traditional software businesses.
Nuvation Bio stock rockets after FDA fast track, but Cramer urges caution
Nuvation Bio shares have surged following a pivotal FDA fast track for its brain cancer drug, but Jim Cramer warns that the company's valuation still hinges on unproven pipeline therapies and volatile clinical outcomes.
Michael Burry bets against Palantir as $432B valuation defies logic
Michael Burry is shorting Palantir, arguing its $432 billion valuation is unsustainable even as revenue surges and AI partnerships multiply. The stock's meteoric rise pits hard financial data against investor euphoria in a high-stakes showdown.
Morgan Stanley hikes Snowflake target $170 as AI revenue accelerates
After three consecutive quarters of accelerating revenue growth fueled by AI adoption and cost discipline, Morgan Stanley has boosted its Snowflake price target by $170, signaling heightened confidence in the company's ability to convert AI momentum into tangible financial results.
Howmet Aerospace Plunge Tests Nerves as SpaceX Sparks Turbine Shock
Elon Musk's SpaceX move to cast its own turbine blades erased billions from Howmet Aerospace's market cap in hours. Analysts and Jim Cramer now see a rare buying window, but warn that Howmet's lofty valuation leaves investors exposed to sharp reversals.
AI-fueled tech giants drive S&P 500 risk to record highs
S&P 500 index funds now expose investors to unprecedented concentration in AI and mega-cap tech stocks, as market cap weighting and rising Treasury yields amplify portfolio risks and challenge assumptions about diversification.
Lululemon Stock Crash Wipes Out $12 Billion as Brand Faces Existential Test
Lululemon shares plunged 18% overnight after a second guidance cut and a 9% drop in comparable sales, erasing $12 billion in market value and intensifying scrutiny of the brand's leadership and future competitiveness.
SpaceX Stock Surges on AI Hype, But Soaring Capex Clouds Outlook
Oppenheimer's bullish $280 target for SpaceX signals 85% upside from current levels, yet the company's $18.4 billion Q2 capex and mounting operational setbacks cast doubt on whether Wall Street's optimism is justified.
Dell's $95 Billion AI Backlog Fuels 41% Stock Upside Bet
A record $95 billion AI server backlog has propelled Dell Technologies into the spotlight, with Bank of America forecasting a 41% stock surge as supply constraints and surging enterprise demand reshape the company's financial trajectory.
Viking Holdings Plunges 20% as River Risks Test Premium Valuation
Shares of Viking Holdings tumbled nearly 20% from August highs amid river cruise disruptions and sector-wide volatility, but Jim Cramer maintains his bullish stance as bookings and profits surge. Investors must weigh premium pricing against operational risks.
The September Effect and Its Impact on AI Stocks in the S&P 500
September has a track record as the S&P 500's weakest month, with average declines of 1.1% since 1928. Heavy exposure to megacap AI stocks and seasonal portfolio rebalancing can amplify volatility and drive investors toward safer assets
Affirm Stock's Hidden Upside: BofA Targets 35% Rally on New Catalysts
Bank of America contends Affirm's conservative forecasts understate its true growth trajectory, citing new initiatives and a 35% upside target that surpasses recent market gains and draws broad Wall Street support.
Buy High and Try Not to Sell: The Rule Breakers Team on Stellar Past Price Appreciation
Investors often hesitate to buy stocks after big gains, but data shows that companies like Guardant Health, Netflix, and Apple have delivered strong long-term returns even after sharp run-ups-if investors resist the urge to sell during downturns
3 Stocks Gaining From Volatility: nVent, Astronics, Eurodry
After the Fed's latest hawkish signals, sharp market swings are creating targeted buying opportunities in nVent, Astronics, and Eurodry-each driven by sector catalysts and distinct financial risks.
CrowdStrike's Record Quarter Redefines Cybersecurity Market Value
CrowdStrike's latest results sent its stock soaring, prompting Wall Street to reassess cybersecurity valuations as AI-driven threats push companies to prioritize security spending.
Jim Cramer: Take Partial Profits on ServiceNow After Stock Rally
ServiceNow shares have rebounded from April lows, prompting Jim Cramer to recommend selling half to secure gains while retaining exposure to the company's AI-driven growth and expanding enterprise partnerships.
Abercrombie's Stock Surge Driven by Tariff Refund, Not Just Sales
Abercrombie & Fitch shares soared nearly 30% after record sales, but a $100 million tariff refund was the main driver of its earnings beat-highlighting the need to separate one-time gains from ongoing retail performance.
Reddit Shares Fall Despite Strong Revenue and Analyst Optimism
Reddit stock has dropped over 30% in 2026, even as the company posts rapid revenue growth and maintains positive analyst ratings, highlighting a disconnect between financial results and market sentiment.
Coca-Cola Unveils Fanta Halloween Campaign to Strengthen Autumn Sales and Margins
Coca-Cola is launching a global campaign to position Fanta as the drink of Halloween, aiming to boost autumn sales, improve margins by reducing licensing costs, and build a new seasonal brand asset.
Alibaba Stock Drops After $10.2B Share Sale Raises Dilution Fears
Alibaba's record Hong Kong share offering triggered an 8% stock drop as investors weighed dilution risks against the company's AI ambitions, just after Michael Burry shifted his position to JD.com
Ron Baron's $24.9 Billion SpaceX Bet Faces Early Losses
Ron Baron has made SpaceX the largest holding in his $66.6 billion portfolio, even as the stock trades below his average cost. His conviction echoes his earlier Tesla strategy, but the risks and scale are even greater this time
Warren Buffett's Successor Greg Abel Invested $23.5 Billion in Stocks Last Quarter, Alphabet Stands Out
Berkshire Hathaway, under Greg Abel's leadership, deployed $23.5 billion into nine stocks last quarter, with Alphabet receiving the largest allocation as the company bets on AI and cloud growth despite market skepticism
Cramer Favors Coca-Cola as Celsius Stock Rallies on Activist Pressure
Celsius shares have surged 16% in a month amid activist calls for leadership change, but Jim Cramer now prefers Coca-Cola, citing recent earnings disappointments and margin pressure at the fast-growing energy drink maker
Druckenmiller Bets Big on Natera as Cancer Testing Surges
Stanley Druckenmiller has made Natera his largest stock holding, increasing his stake even as shares hit record highs. The move highlights a shift in focus toward healthcare diagnostics with steady demand and strong revenue growth
Page 1 by 3